Marino, N. D., Pinilla-Redondo, R. , Csorgo, B., Bondy-Denomy, J.,
Nature Methods,
2020.
Clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool and therapeutic. The discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPR (Acr) proteins, enables the development of more controllable and precise CRISPR-Cas tools. Here we discuss applications of Acr proteins for post-translational control of CRISPR-Cas systems in prokaryotic and mammalian cells, organisms and ecosystems. This Review highlights recent discoveries and applications of anti-CRISPR (Acr) proteins that enable the regulation of CRISPR-Cas technology.
https://www.geneconvenevi.org/wp-content/uploads/2020/04/Nature-Methods.png300300David Obrochta/wp-content/uploads/2019/10/GC-color-logo-for-header-3277-x-827-1030x260.pngDavid Obrochta2020-03-16 13:52:422020-04-29 19:56:42Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies